Zacks Investment ResearchWed, 25 Mar 2026 15:10:50 GMTRezolute Stock Gains After FDA Meeting on Ersodetug Program UpdateRZLT+0.91%
BenzingaTue, 24 Mar 2026 18:00:36 GMTFDA Review Puts Rezolute's Genetic Disorder Drug Path In QuestionRZLT+0.91%